John B. Kaiser

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

Crdentia Corp. provides healthcare staffing services, focusing on the areas of travel nursing, per diem staffing, contractual clinical services, and private duty home care. The company was founded in November 10, 2004 and is headquartered in Winter Park, FL.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

Crdentia Corp. provides healthcare staffing services, focusing on the areas of travel nursing, per diem staffing, contractual clinical services, and private duty home care. The company was founded in November 10, 2004 and is headquartered in Winter Park, FL.

Crdentia Corp. provides healthcare staffing services, focusing on the areas of travel nursing, per diem staffing, contractual clinical services, and private duty home care. The company was founded in November 10, 2004 and is headquartered in Winter Park, FL.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

Crdentia Corp. provides healthcare staffing services, focusing on the areas of travel nursing, per diem staffing, contractual clinical services, and private duty home care. The company was founded in November 10, 2004 and is headquartered in Winter Park, FL.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.